352 related articles for article (PubMed ID: 31953128)
21. Optimization and Evaluation of Novel Antifungal Agents for the Treatment of Fungal Infection.
Choi JW; Lee KT; Kim S; Lee YR; Kim HJ; Seo KJ; Lee MH; Yeon SK; Jang BK; Park SJ; Kim HJ; Park JH; Kim D; Lee DG; Cheong E; Lee JS; Bahn YS; Park KD
J Med Chem; 2021 Nov; 64(21):15912-15935. PubMed ID: 34662122
[TBL] [Abstract][Full Text] [Related]
22. Organic Antifungal Drugs and Targets of Their Action.
Maksimov AY; Balandina SY; Topanov PA; Mashevskaya IV; Chaudhary S
Curr Top Med Chem; 2021; 21(8):705-736. PubMed ID: 33423647
[TBL] [Abstract][Full Text] [Related]
23. [In vitro antifungal activity of micafungin].
Quindós G; Eraso E; Javier Carrillo-Muñoz A; Cantón E; Pemán J
Rev Iberoam Micol; 2009 Mar; 26(1):35-41. PubMed ID: 19463275
[TBL] [Abstract][Full Text] [Related]
24. Systemic Antifungal Agents: Current Status and Projected Future Developments.
Seyedmousavi S; Rafati H; Ilkit M; Tolooe A; Hedayati MT; Verweij P
Methods Mol Biol; 2017; 1508():107-139. PubMed ID: 27837500
[TBL] [Abstract][Full Text] [Related]
25. Antifungals targeted to protein modification: focus on protein N-myristoyltransferase.
Georgopapadakou NH
Expert Opin Investig Drugs; 2002 Aug; 11(8):1117-25. PubMed ID: 12150705
[TBL] [Abstract][Full Text] [Related]
26. Probiotics as antifungal agents: Experimental confirmation and future prospects.
Kosgey JC; Jia L; Fang Y; Yang J; Gao L; Wang J; Nyamao R; Cheteu M; Tong D; Wekesa V; Vasilyeva N; Zhang F
J Microbiol Methods; 2019 Jul; 162():28-37. PubMed ID: 31071354
[TBL] [Abstract][Full Text] [Related]
27. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
Pedersen TR
Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
[TBL] [Abstract][Full Text] [Related]
28. Antifungals discovery: an insight into new strategies to combat antifungal resistance.
Fuentefria AM; Pippi B; Dalla Lana DF; Donato KK; de Andrade SF
Lett Appl Microbiol; 2018 Jan; 66(1):2-13. PubMed ID: 29112282
[TBL] [Abstract][Full Text] [Related]
29. Synergistic and antagonistic drug interactions in the treatment of systemic fungal infections.
Wambaugh MA; Denham ST; Ayala M; Brammer B; Stonhill MA; Brown JC
Elife; 2020 May; 9():. PubMed ID: 32367801
[TBL] [Abstract][Full Text] [Related]
30. Peptide-Like Nylon-3 Polymers with Activity against Phylogenetically Diverse, Intrinsically Drug-Resistant Pathogenic Fungi.
Rank LA; Walsh NM; Lim FY; Gellman SH; Keller NP; Hull CM
mSphere; 2018; 3(3):. PubMed ID: 29794056
[TBL] [Abstract][Full Text] [Related]
31. Posaconazole: a broad-spectrum triazole antifungal.
Torres HA; Hachem RY; Chemaly RF; Kontoyiannis DP; Raad II
Lancet Infect Dis; 2005 Dec; 5(12):775-85. PubMed ID: 16310149
[TBL] [Abstract][Full Text] [Related]
32. [In vitro antifungal activity of voriconazole: New data after the first years of clinical experience].
Quindós G; Carrillo-Muñoz AJ; Eraso E; Cantón E; Pemán J
Rev Iberoam Micol; 2007 Sep; 24(3):198-208. PubMed ID: 17874856
[TBL] [Abstract][Full Text] [Related]
33. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
Espinel-Ingroff A
Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
[TBL] [Abstract][Full Text] [Related]
34. Growth inhibition of Candida species and Aspergillus fumigatus by statins.
Macreadie IG; Johnson G; Schlosser T; Macreadie PI
FEMS Microbiol Lett; 2006 Sep; 262(1):9-13. PubMed ID: 16907733
[TBL] [Abstract][Full Text] [Related]
35. Antifungal activity of redox-active benzaldehydes that target cellular antioxidation.
Kim JH; Chan KL; Mahoney N; Campbell BC
Ann Clin Microbiol Antimicrob; 2011 May; 10():23. PubMed ID: 21627838
[TBL] [Abstract][Full Text] [Related]
36. Development and research progress of anti-drug resistant fungal drugs.
Cui X; Wang L; Lü Y; Yue C
J Infect Public Health; 2022 Sep; 15(9):986-1000. PubMed ID: 35981408
[TBL] [Abstract][Full Text] [Related]
37. Antifungal drug resistance: does it matter?
Rogers TR
Int J Infect Dis; 2002 Mar; 6 Suppl 1():S47-53. PubMed ID: 12044289
[TBL] [Abstract][Full Text] [Related]
38. Antifungal therapy with an emphasis on biofilms.
Pierce CG; Srinivasan A; Uppuluri P; Ramasubramanian AK; López-Ribot JL
Curr Opin Pharmacol; 2013 Oct; 13(5):726-30. PubMed ID: 24011516
[TBL] [Abstract][Full Text] [Related]
39. Repurposing antipsychotic drugs into antifungal agents: Synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections.
Holbrook SYL; Garzan A; Dennis EK; Shrestha SK; Garneau-Tsodikova S
Eur J Med Chem; 2017 Oct; 139():12-21. PubMed ID: 28797882
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo evaluation of antifungal agents.
Espinel-Ingroff A; Shadomy S
Eur J Clin Microbiol Infect Dis; 1989 Apr; 8(4):352-61. PubMed ID: 2497014
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
